In Clarity the Severity and Frequency of Relapses Are Lower in Patients with Relapsing-remitting Multiple Sclerosis Treated with Cladribine Tablets Versus Placebo

S. Schippling, M. P. Sormani, N. De Stefano, G. Giovannoni, A. Galazka, B. Keller, N. Alexandri